These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 5885635)

  • 1. [(Round table conference). Advances in the treatment of hematologic diseases].
    Nakao K; Miwa S; Maekawa T; Amagi K; Suzuki H
    Naika; 1965 Oct; 16(4):708-24. PubMed ID: 5885635
    [No Abstract]   [Full Text] [Related]  

  • 2. [Round table conference. Congenital hematologic diseases].
    Nihon Ketsueki Gakkai Zasshi; 1966 Jun; 29(3):432-44. PubMed ID: 6006095
    [No Abstract]   [Full Text] [Related]  

  • 3. Current advances in drugs used for hematologic disorders.
    Jim RT; Lumeng J
    Hawaii Med J; 1988 Oct; 47(10):472, 477. PubMed ID: 3069802
    [No Abstract]   [Full Text] [Related]  

  • 4. [Round table conference. Refractory cases in internal medicine and their management. II. Circulatory system, kidney, blood and digestive tract].
    Yoshitoshi Y; Hosono S; Hatano M; Miwa S; Niwa H
    Naika; 1969 Dec; 24(6):1075-92. PubMed ID: 5360074
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drugs used in the treatment of hematologic diseases].
    Takaku F; Maezawa M
    Kango Gijutsu; 1977 Apr; 23(6):85-95. PubMed ID: 585390
    [No Abstract]   [Full Text] [Related]  

  • 6. Proteasome inhibition: a new approach to the treatment of hematologic diseases.
    J Natl Compr Canc Netw; 2004 Nov; 2 Suppl 4():S-iv. PubMed ID: 19791421
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention of hyperuricemia and its complications with allopurinol, in the treatment of several hematologic diseases].
    Rapado Errazti A; Torres González JA
    Rev Clin Esp; 1966 Nov; 103(4):296-301. PubMed ID: 5999583
    [No Abstract]   [Full Text] [Related]  

  • 8. Inside Haematologica: caution in the use of thalidomide for treatment of hematologic disorders.
    Haematologica; 2002 Apr; 87(4):345-6. PubMed ID: 11940477
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of hematologic patients with the hypophyseal preparation Erypoetin].
    Cherntsova TA; Zvereva LA; Kakhetelidze MG; Gudim VI; Moskaleva GP; Propisnova NG
    Sov Med; 1968 Apr; 31(4):96-9. PubMed ID: 5669784
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of androgens in the treatment of hematologic disorders.
    Ammus SS
    Adv Intern Med; 1989; 34():191-208. PubMed ID: 2644756
    [No Abstract]   [Full Text] [Related]  

  • 11. Hematologic effects of androgens revisited: an alternative therapy in various hematologic conditions.
    Besa EC
    Semin Hematol; 1994 Apr; 31(2):134-45. PubMed ID: 8066470
    [No Abstract]   [Full Text] [Related]  

  • 12. [Steroid therapy in hematologic diseases and neoplasms].
    Huber H; Goldberg K; Fellner H
    Med Welt; 1965 Sep; 39():2223-8. PubMed ID: 5862874
    [No Abstract]   [Full Text] [Related]  

  • 13. Interferon in hematologic malignancies and related disorder.
    Semin Hematol; 1990 Jul; 27(3 Suppl 4):1-36. PubMed ID: 1695762
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the use of sex hormones in the treatment of some diseases of the blood system].
    Riabov SI
    Ter Arkh; 1965 Sep; 37(9):30-4. PubMed ID: 5870402
    [No Abstract]   [Full Text] [Related]  

  • 15. [Interferons in the treatment of hematological diseases].
    Jantunen E; Nousiainen T
    Duodecim; 1998; 114(12):1240-7. PubMed ID: 11524770
    [No Abstract]   [Full Text] [Related]  

  • 16. Guidelines for the use of intravenous immune globulin for hematologic and neurologic conditions.
    Hume HA; Anderson DR
    Transfus Med Rev; 2007 Apr; 21(2 Suppl 1):S1-2. PubMed ID: 17397766
    [No Abstract]   [Full Text] [Related]  

  • 17. Is management with lamivudine always the appropriate choice for HBV patients with onco-hematologic diseases?
    Cox MC; Marignani M; Veggia B; Angeletti S; Leone F; Cipriani P; Gallina S; Delle Fave G; Aloe-Spiriti MA; Monarca B
    Ann Hematol; 2009 Mar; 88(3):283-4. PubMed ID: 18807036
    [No Abstract]   [Full Text] [Related]  

  • 18. Rituximab in the treatment of autoimmune haematological disorders.
    Provan D; Newland AC; Amadori S; Stasi R
    Br J Haematol; 2008 Oct; 143(2):294; author reply 295. PubMed ID: 18752592
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral megadose methylprednisolone administration in hematologic disorders.
    Ozsoylu S
    Pediatr Hematol Oncol; 1994; 11(5):565, 563-4. PubMed ID: 7826852
    [No Abstract]   [Full Text] [Related]  

  • 20. Morphological features following G-CSF treatment.
    Azzarà A; Carulli G
    Haematologica; 1997; 82(4):504-5. PubMed ID: 9299872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.